MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Laboratory Corp of America Holdings

Closed

Sector Healthcare

249.13 0.06

Overview

Share price change

24h

Current

Min

249.13

Max

250.62

Key metrics

By Trading Economics

Income

-36M

170M

Sales

47M

3.3B

P/E

Sector Avg

28.002

73.394

EPS

3.45

Dividend yield

1.16

Profit margin

5.168

Employees

70,000

EBITDA

-206M

217M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+10.9 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.16%

3.09%

Next Earnings

24 Apr 2025

Next Dividend date

12 Mar 2025

Next Ex Dividend date

27 Feb 2025

Market Stats

By TradingEconomics

Market Cap

21B

Previous open

249.07

Previous close

249.13

News Sentiment

By Acuity

29%

71%

67 / 393 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Laboratory Corp of America Holdings Chart

Past performance is not a reliable indicator of future results.

Related News

22 Feb 2025, 00:16 UTC

Hot Stocks

Stocks to Watch: Alamos Gold, Booking Holdings

22 Feb 2025, 16:33 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 15:15 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 14:32 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 13:49 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 13:22 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

21 Feb 2025, 23:22 UTC

Top News

DOGE Aide's IRS Access Won't Include Personal Information -- Update

21 Feb 2025, 23:20 UTC

Earnings

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

21 Feb 2025, 22:34 UTC

Market Talk

L'Oréal Cuts Exposure to Chinese Market, Grows Emerging Markets -- Market Talk

21 Feb 2025, 22:12 UTC

Top News

DOJ Investigates Medicare Billing Practices at UnitedHealth -- 2nd Update

21 Feb 2025, 21:54 UTC

Top News

Why Is Warren Buffett Hoarding So Much Cash? -- 2nd Update

21 Feb 2025, 21:51 UTC

Earnings

Tesla Stock Falls. Recalls and Rivian Are in the News. -- Barrons.com

21 Feb 2025, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

21 Feb 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 Feb 2025, 21:50 UTC

Top News

DOGE Aide's IRS Access Won't Include Personal Information -- WSJ

21 Feb 2025, 21:48 UTC

Market Talk
Earnings

L'Oréal Tops Estée Lauder in Luxury U.S. Market, CEO Says -- Market Talk

21 Feb 2025, 21:35 UTC

Market Talk

Bulk of U.S. Imports From Canada Used to Make U.S. Goods -- Market Talk

21 Feb 2025, 21:28 UTC

Top News

Why Is Warren Buffett Hoarding So Much Cash? -- Update

21 Feb 2025, 21:24 UTC

Top News

Major U.S. Stock Indexes Give Up Gains From the Week -- WSJ

21 Feb 2025, 21:19 UTC

Market Talk

Mexico's Inflation Seen Up in Early February -- Market Talk

21 Feb 2025, 20:15 UTC

Market Talk

Global Equities Roundup: Market Talk

21 Feb 2025, 20:15 UTC

Market Talk

JPMorgan Chase Branch Expansion Portends Deposit Growth -- Market Talk

21 Feb 2025, 20:05 UTC

Market Talk

Oil Futures Retreat Into the Weekend Again -- Market Talk

21 Feb 2025, 19:58 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Gain -- Market Talk

21 Feb 2025, 19:29 UTC

Market Talk

Gold Slides After Finding Record High -- Market Talk

21 Feb 2025, 19:26 UTC

Top News

Major U.S. Stock Indexes Slip; UnitedHealth Pulls Down DJIA -- WSJ

21 Feb 2025, 19:05 UTC

Market Talk

Business Conditions Seen as Favoring Corporate Credit -- Market Talk

21 Feb 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

21 Feb 2025, 19:02 UTC

Market Talk

Corporate Credit Expected to Be Hit Unevenly by Trade Wars -- Market Talk

21 Feb 2025, 19:00 UTC

Market Talk

Long-Term Treasury Yields Expected to Rise -- Market Talk

Peer Comparison

Price change

Laboratory Corp of America Holdings Forecast

Price Target

By TipRanks

10.9% upside

12 Months Forecast

Average 277.08 USD  10.9%

High 293 USD

Low 248 USD

Based on 13 Wall Street analysts offering 12 month price targets forLaboratory Corp of America Holdings - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

10

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

196.14 / 197.94Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

67 / 393 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.